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Abstract
Background: Increased patient demand for healthcare services coupled with a shortage of general practitioners
necessitates changes in professional roles and service delivery. In 2016, NHS England began a 3-year- pilot study of
pharmacists in general practice, however, this is not an entirely new initiative. There is limited, current, evidence-based,
UK research to inform the pilot so studies of pre-existing services must suffice until findings from a formal national
evaluation are available.
Methods: The aim of this exploratory, descriptive interview study was to explore the experiences of stakeholders in
eight general practices in the Ealing GP Federation, West London, where pharmacy services have been provided for
several years. Forty-seven participants, including pharmacy team members (pre-registration and clinical pharmacists,
independent prescribers and pharmacy technicians), general practitioners, patients, practice managers, practice nurses
and receptionists took part in semi-structured, audio-recorded qualitative interviews which were transcribed verbatim,
coded and analysed thematically to extract the issues raised by participants and the practicalities of providing
pharmacy services in general practice.
Results: Findings are reported under the themes of Complementarity (incorporating roles, skills, education and
workloads); Integration (incorporating relationships, trust and communication) and Practicalities (incorporating location
and space, access, and costs). Participants reported the need for time to develop and understand the various roles,
develop communication processes and build inter-professional trust. Once these were established, however,
experiences were positive and included decreased workloads, increased patient safety, improved job satisfaction,
improved patient relationships, and enhanced cost savings. Areas for improvement included patients’ awareness of
services; pharmacists’ training; and regular, onsite access for practice staff to the pharmacy team.
Conclusions: Recommendations are made for the development of clear role definitions, identification of training
needs, dedication of time for team building, production of educational materials for practice staff members and
patients, and provision of on-site, full-time pharmacy services. Future work should focus on evaluation of various
models of employing pharmacy teams in general practice; integration of pharmacists and pharmacy technicians into
multidisciplinary general practice teams; relationships between local community pharmacy and general practice
personnel; and patients’ service and information needs. A formal national evaluation of the pilot scheme is overdue.
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Background
Currently, there is a nationwide shortage of 8000
General Practitioners (GPs) across the UK [1]. In contrast,
there is a surplus of registered pharmacists, with the ex-
cess number, according to The Centre for Workforce
Intelligence, expected to be 11,000–19,000 by 2040 [1] if
roles remain unchanged. As a result, in 2015 the Royal
Pharmaceutical Society (RPS), in collaboration with the
Royal College of General Practitioners (RCGP), proposed
further integration of pharmacists into general practices
outlining the various benefits that pharmacists could pro-
vide. In 2015, NHS England announced a 3-year pilot at a
cost of £31 million to test the role of pharmacists working
in general practices, which resulted in 490 pharmacists
employed across approximately 650 practices. In early
2017 further funds (£122 million) were committed to sup-
port an extra 1500 positions by 2020/21 [2].
Having a pharmacist in a general practice team is not
new [3]. Because of recent changes in, and rapid devel-
opment of, the role of pharmacists, there is limited
current UK research that could inform the pilot [4, 5].
Alongside impact metrics, work is needed on pre-
existing collaborations. Early pilot sites can provide
preliminary insights into the practicalities, benefits and
barriers of employing pharmacists in general practice,
multidisciplinary team development, and stakeholder ex-
periences of service provision. One pre-existing collabor-
ation, now a pilot site, is in the Ealing GP Federation in
West London. In 2016, eight practices serving approxi-
mately 70,000 patients had already been contracting a
private company to provide pharmacy-related services
for approximately 3 years prior to the pilot. The phar-
macy team, at that time, was comprised of a prescribing
lead pharmacist (manager), lead pharmacy technician,
field-based clinical diploma pharmacist, six prescribing
pharmacists, six technicians, a pre-registration trainee
pharmacist and prescription delivery drivers. They pro-
vided a variety of services, including face-to-face medica-
tion reviews; long term condition, repeat prescription
and medication management; triage; and acute care.
Some services were provided in the general practice and
some in domiciliary settings, including surrounding resi-
dential aged-care and nursing homes. The Ealing GP
Federation model of integration of pharmacy services
into general practice is probably unique in employing
pharmacy technicians but no work has been done to de-
termine the variety of integrating models in existence
across the UK. Because of its pre-existing nature, this
model provides a timely case study to give insight into
how integration might evolve given time.
International studies, mostly in Australia, New Zealand
and Canada, have primarily focussed on the experiences of
GPs, pharmacists and patients [4–15] and have shown posi-
tive GP responses towards the integration of pharmacists
into general practices. GPs recognised that having a
practice-based pharmacist decreased their workload and
allowed them to focus on their diagnostic and prescribing
roles, while pharmacists provided expert medication advice
and patient counselling [4, 10, 14]. Potential barriers to in-
tegrating pharmacists into general practices were cited as a
lack of readiness in patients to accept them; the perceptions
of an already established and rigid hierarchy amongst exist-
ing staff within the general practice; and the limited time
that pharmacists spent there [8, 10, 11, 13]. Gaps in the lit-
erature include the experiences of other stakeholders in-
volved in the patient’s care. Therefore, in this exploratory
study we interviewed six stakeholder groups aligned with
the Ealing GP Federation (pharmacy team members, GPs,
patients, practice managers, receptionists and nurses) to an-
swer the question: What are the experiences of the various
stakeholders in a group of general practices currently
employing pharmacists?
In an attempt to inform future development of new
pilot sites, in this paper we provide a descriptive report
of stakeholders’ experiences and outline their views on
the practicalities of setting up and maintaining pharmacy
services in general practice.
Methods
A pair of researchers, from a group of 12 final year Mas-
ter of Pharmacy students was assigned to each one of
the six stakeholder groups. The aim was to interview up
to 12 people, unknown to the researchers, from each
group to capture a wide range of experiences. The re-
searchers received qualitative interview training from
supervisors with qualitative expertise and were given
detailed feedback on their early interviews. In-depth,
semi-structured, face-to-face interviews were conducted
during Jan-Mar 2016.
All staff members at the practices were contacted by
email by the lead pharmacy technician. They were pro-
vided with a copy of the invitation letter, participant in-
formation sheet and consent form and asked to notify
the lead pharmacy technician of their willingness to par-
ticipate. A time was then arranged for the interview.
One follow-up email was sent approximately 2 weeks
after the first.
Eligible patients (aged 18 or above, competent to give
informed consent and English language speakers) were
identified by the lead pharmacy technician at the time of
booking a medication review appointment with the lead
pharmacist. Patients were provided with an invitation
letter, participant information sheet and consent form
and invited to take part. Once consent was obtained the
interview was scheduled directly after the patient’s medi-
cation review with the pharmacist.
All participants who agreed to be interviewed gave
their written, informed consent before participating in
Ryan et al. BMC Health Services Research  (2018) 18:234 Page 2 of 13
the study. Semi-structured, in-depth interview guides
were developed by the research team based on the
known nature of the participants’ roles and findings
from the scant published literature from overseas
(Additional file 1). Questions were designed to allow
participants to talk in a conversational manner about
their experiences in their own terms. Open-ended ques-
tions, such as “What are your roles and responsibilities
in this GP surgery?”, “Tell me about your experiences of
having/being a pharmacist working in this GP surgery”
and “How have pharmacists in this GP surgery affected
healthcare provision?” were followed up with prompts,
for example about experiences, workloads, quality of re-
lationships, feelings, barriers and facilitators to elicit
more detailed answers. Interviews were largely guided by
the participants themselves and they chose what to dis-
cuss and how much to disclose. All interviews took place
in a private area of the general practices.
The interviews were audio-recorded and given a code ac-
cording to their stakeholder group and interview number
(for example GP1 = general practitioner 1; M1 =manager 1;
N1 = nurse 1; PA1 = patient 1; P1 = pharmacist 1; IP1 =
independent pharmacist 1; CP1 = clinical pharmacist 1;
PT = pharmacy technician; R1 = receptionist 1 etc). The
recordings were downloaded to password protected
computers as soon as practicable, after which the audio
recorders were cleared. Interviews were transcribed
verbatim with all information anonymised, checked by
each pair of researchers, and stored on a university
password protected server. The first interview tran-
script was reviewed by the lead researchers with each
pair who were encouraged to be reflexive about their
techniques, and feedback was provided before further
interviews were scheduled.
For this paper, data from each pair of student re-
searchers was pooled by another researcher (HAE),
managed using NVivo 11 (QSR International), coded in-
ductively from the interview transcripts and analysed
using interpretive thematic analysis [16, 17] and constant
comparison [18]. The research team met regularly
throughout the data analysis process to reduce the
possibility of researcher bias. Potential categories were
identified, discussed by the authors and confirmed by
detailed re-reading of the transcripts. Further refine-
ment and reduction occurred until a final list of
categories was obtained and agreed by all the lead re-
searchers. The themes were then finalized by collapsing
categories under descriptive titles that reflected the
content of the data and addressed the aim of the study.
Illustrative quotes, that represented the range of stake-
holders, their experiences of pharmacists in general
practice, the issues they raised and the analytical points
being made, were selected for reporting and appear in
the text in italics.
Results
Forty-seven stakeholders took part in interviews lasting
15–45 min. Table 1 shows the number interviewed and
the total number of potential interviewees in each stake-
holder group together with basic demographics. To
guarantee anonymity, further demographic details could
not be included. It can be seen that reasonable numbers
of potential general practice staff participants were inter-
viewed which provides credibility that the widest pos-
sible range of experiences and opinions was obtained.
Only nine patients were available for interview in the
time frame allocated.
Figure 1 illustrates the three main themes and (inter-re-
lated) subthemes of practical significance derived from the
data that are presented here: Complementarity (incorpor-
ating roles, skills, education and workloads), Integration
(incorporating relationships, trust and communication)
and Practicalities (incorporating location and space, access
and costs).
Complementarity
Complementarity is defined, by the Oxford Dictionary of
English, as a relationship or situation in which two or
more different things improve or emphasize each other’s
qualities. Participants discussed the complementary na-
ture of their roles and skills and the contribution, such
as decreased workloads, that pharmacists made to the
multi-disciplinary team. They also talked about the need
for appropriate educational training and a clear under-
standing of professional competencies.
Roles
Roles identified for the pharmacy team included face-to-
face appointments with patients to manage long term
conditions, polypharmacy, medicines optimisation and
patient monitoring; spirometry clinics; treatment of
common ailments; telephone triage of medicines en-
quiries; management of repeat prescriptions; reconcili-
ation of discharge summaries; Quality and Outcomes
Framework (QoF) monitoring and reporting; and the
completion of prescribing audits. The pharmacy team
was supervised by an experienced lead pharmacist and
pharmacy technician. All pharmacists had a patient fa-
cing role and those who had completed independent
prescribing shared responsibility for authorising pre-
scriptions. All practitioners were required to act within
their respective competency. Clinics were booked up to
a month in advance by receptionists, GPs and nurses.
Pharmacists received mentorship by the lead pharmacist
and a named GP. Technicians were trained and super-
vised by the lead pharmacist and pharmacy technician.
The processing of prescriptions was done both on site
and remotely using IT solutions (bespoke electronic sys-
tems and support) including N3 (national broadband
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network for the NHS in England) connected secure
laptops with access to SystmOne (the medical records
software), on-line ordering for patients, scanning of
paper orders and letters and NHS net secure email. Use
of electronic transmission of prescriptions to community
pharmacies wherever possible and secure transport of
paperwork by drivers was also deployed.
They do medication reviews… they do rounds in
nursing homes where they check all medication is
being used appropriately… medication control and
health promotion, lifestyle advice all those sort of
things, could definitely be done by the pharmacist.
So there is definitely more roles for pharmacists in
general practice (M2).
The arguably unique feature of the Ealing GP Federation
model of pharmacy services provision is the novel man-
agement of repeat prescriptions utilising the expertise of
pharmacy technicians which was described as a light
bulb moment (GP2). There was a strong belief amongst
receptionists and managers that their previous in-
volvement in repeat prescribing was beyond their skillset
and participants reported being more confident (M5) in
a process that was much safer (R3) under the supervi-
sion of a pharmacist. Repeat prescription requests, for
Table 1 Characteristics of stakeholder participants (n = no. of interviewees/total pool)
Demographic Stakeholder group
GP
(n = 7/50)
Nurse
(n = 6/18)
Manager
(n = 8/9)
Patient
(n = 9)
Pharmacist
(n = 5/8)a
Pharmacy technician
(n = 4/6)
Receptionist
(n = 8/43)
Age (yrs)
< 25 1 1
25–34 2 2 2 1
35–44 3 1 2 1
45–54 1
55–65 1 1
> 65 1 4 1
Missing 1 5 8 5 4
Time at practice (yrs)
< 5 3 3 8 1 4 4 5
5–10 2 1 3
11–15 1 1 2
15–20 1 1
> 20 1 1 1b
aPharmacist group includes one pre-registration pharmacist
bUnable to obtain the time at the practice for 4 patients
Fig. 1 Analytical themes and sub-themes
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example, were referred by the receptionists to the phar-
macy team and were processed and issued according to a
“48-h turnaround” protocol. The pharmacy technicians
referenced the prescription request against the protocol
and patient medical records and, if set criteria (such as an
appropriate blood test, medication review and compliance
with local formulary) were met, the prescriptions were
generated for a signature, most commonly from the pre-
scribing pharmacist or, where appropriate for items
requiring medical input, the patient’s GP. Medication re-
views were directed by the technicians to the most appro-
priate healthcare professional, such as a GP, nurse or
practice pharmacist. Alternatively, patients had the option
to directly make an appointment to see the pharmacist if
they wished to discuss medication-related concerns.
Many members of staff reported increased under-
standing of the role of pharmacists in general practice
although awareness remained limited for some recep-
tionists, nurses, managers and patients.
It took us a while to get the nurses to realise that when
we refer to the pharmacy team, they were different
from their chemist shop and that caused confusion at
the beginning (M4).
Let’s say the situation is whether to continue a
medication the patient is on or specifically when
patients complain about medication. A pharmacist
will not be able to answer that. It’s more clinical so I’d
refer to see a GP… I don’t think the practice is that
desperate for a pharmacist (N6).
It was suggested that to facilitate effective working be-
tween pharmacists and other practitioners you’d have to
have regular meetings to help understand what each
other’s roles are (N1). All staff members identified the
pharmacy team’s added contribution to the practice
through educational talks.
We had a meeting with the prescribing advisor which the
pharmacy team came to, that was quite a good
discussion, particularly having a pharmacist there who
really knows their stuff… It was a different conversation
than previous prescribing meetings… a lot more focused
on particular medication and latest evidence (M2).
Pharmacists and technicians described increased job
satisfaction derived from their extended roles, including
involvement in patient care, greater use of their skills
and increased responsibility.
It really diversifies my role, so I don't feel like I'm just
stuck in the dispensary. I feel like I'm empowered to
help patients to a greater degree (IP2).
This is the best job I've had, because… I see the whole
patient history, I see hospital letters, I see pathology, I
see the whole picture. Whereas in the community
pharmacy I could only see what they had come in
with, the medicines (IP1).
Future roles were discussed by GPs and managers.
They identified the potential for pharmacists’ increased
involvement in the management of long-term conditions
and the establishment of a minor ailments clinic. One
manager identified a potential future role for a phar-
macy technician healthcare assistant with knowledge
about medication and... [the ability to] take blood pres-
sure, weight, height, all those kind of things (M2).
Skills
Members of every stakeholder group thought that phar-
macists had a strong knowledge of medications, citing
many instances in which they had used the pharmacy
team for information and advice. GPs and nurses de-
scribed the pharmacists’ knowledge of medications as
superior to their own.
Their knowledge is way over and above anything we
know about drug interactions. (The pharmacist) can
just look at a list of medications “They shouldn’t be on
that, they should be on this” and he’s very, very good at
picking up on the subtleties of medication interactions
and the NICE guidance (GP6).
Two patients (PA3 & PA5) believed that the pharma-
cist knew more about medication than the doctors (PA3).
Several said that they had not previously thought to ask
about their medicines and that the information they
received from the pharmacist was beneficial and import-
ant, concluding that the pharmacist was the most appro-
priate person to speak to for medication related queries.
I don’t even need to see a doctor… (The pharmacist is)
so good she explains everything… not that I mind one
or the other but… I can see that the pharmacist for me
is all I need (PA7).
GPs acknowledged the varied skills that they felt the
pharmacy team possessed outside their defined roles, cit-
ing the pharmacists’ ability to counsel beyond pharma-
cological management including holistic health and
lifestyle advice, their ability to apply their knowledge in a
practical setting and their methodical approach.
(The pharmacist) has an interest in elderly care so he
doesn’t always go to pharmacological management. He
would be able to advise outside that as well and… he
understands intrinsically the importance of not just
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rushing into polypharmacy in elderly patients…. It is
quite holistic actually and it’s quite easy for a lot of
doctors to fall into that trap. So he will just say “Why
not think about this or think about that”. I found that
quite useful (GP3).
Participants also described increased efficiency within
the general practice in dealing with the repeat prescribing
process with one manager (M1) reporting a reduction in
medication-related complaints. There was concern, how-
ever, from two GPs and a nurse, but without evidence,
that lack of involvement might lead to them (or younger
GPs) losing confidence (GP7) and becoming deskilled
(GP4), through non-engagement with (repeat) prescribing
and loss of continuity of patient care, resulting in reduced
knowledge of patients’ current medications. This, however,
was not a universal sentiment.
Some GPs are worried about getting deskilled about
repeat prescribing, I don’t think it’s any great loss, the
patients are safer as such. I am not bothered as it’s
their safety, patient safety is better (GP3).
Education
Some pharmacists expressed the need for postgraduate
training, believing that the knowledge they gained from
a pharmacy degree and pre-registration year was insuffi-
cient to work effectively in general practice.
It's not simply coming out of university and working in
a GP surgery - that would be very uncommon, you
would need further training, either through your
pre-reg or after you've done your pre-reg, a diploma or
something (IP2).
Some pharmacy technicians also expressed a desire for
further training feeling that they were initially under-
equipped for their role.
Although pharmacists readily identified the bound-
aries of their expertise, one GP repeatedly expressed
concerns that a pharmacist might act outside of their
professional competencies.
The major risk for me, if you get some pharmacists
working in practices in a clinical role, is them not
knowing what they don’t know (GP2).
Workloads
All GPs stated that the introduction of a pharmacy team
reduced their involvement in medication management,
facilitated more appropriate use of their skills, and
allowed them to increase their patient-facing activity
leading to improved relationships.
It’s brilliant having (a pharmacist)… they are a
fantastic resource but they are also significantly
reducing our workload (GP6).
You are going to be seeing more patients during the
day, you get to know your patients better rather than
just dealing with looking at the computer doing
medications. When you’re doing medication reviews
you get a lot of patients that are on six, seven, ten plus
medications and arranging that takes a bit of time so
you are not spending that with your patient. You are
not giving your full concentration and it does affect
your patient-doctor relationship (GP7).
(Repeat prescriptions are) a hugely time consuming
thing, I think doctors were spending a good half hour,
40 minutes [a day] on prescriptions. Equally a lot of
our on-call sessions would be dealing with script
queries from patients, them saying they had ordered
something and it hadn’t arrived that kind of stuff. So
all of that has been skimmed off the top of our
workload basically, so it is quite a big impact on staff
and doctors as well (GP5).
Changes in workloads were not limited to GPs with re-
ceptionists, managers and nurses also reporting a reduc-
tion. One receptionist (R6) revealed that, prior to the
pharmacy teams’ introduction, they were tempted to
leave due to their high workload but now believes that
this has allowed them to increase their focus on individ-
ual patient needs rather than medication queries.
Although occasionally there were concerns raised over
a high workload, the pharmacy team’s experiences were
overwhelmingly positive.
Often the demand and the expectations of what one
person can actually do in the time allocations
(are too high) (IP2).
One pharmacy technician (PT1), however, thought that
the receptionists unnecessarily relied upon them refer-
ring queries that they, the receptionists, could have dealt
with themselves.
Integration
Introduction of a pharmacy team into general practices
incurred some initial hurdles around building trusting
relationships both within the practice and with sur-
rounding community pharmacies but with time and
good communication this group of practices was able to
overcome most of the barriers.
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Relationships
Most participants reported positive and healthy profes-
sional and personal relationships between the pharmacy
team and the rest of the practice staff with little hesitation
in approaching the team with queries and vice versa.
My relationships with the doctors are very good. I can
knock (on the door of ) any doctor at any time and
discuss a case. For example, if I'm not happy with a
particular medication or I feel not comfortable in
signing the prescription I want to speak to the last
doctor who has actually seen the patient (IP3).
It’s nice, everyone helps each other, things are done on
time. If they (the pharmacy team) make a mistake, they
fix it, so there are never really any issues. Best thing
they’ve done was get them here, I think (laughs) (R6).
I think some of the doctors probably have a close
networking relationship (with the pharmacists), the
partners for example. We [GP partners] initially met
them and employed them so for example today I had a
patient call up, and I sent a quick instant message to
[Pharmacy technician] who was upstairs and asked him
“What would you suggest as an alternative?” and then 2
minutes later the patient could have their prescription,
all done and dusted. Equally with [Pharmacist] who is
obviously in charge of the whole thing. He is very happy
for us to drop him an email and usually replies very
quickly if you need advice or anything like that, and we
all get on very well on a personal level too. He comes to
our Christmas parties. So yeah we’ve found that there’s
also a lot of informal support as well [as] with the
actual day to day business of regenerating prescriptions
for us and things (GP5).
Pharmacy technicians and receptionists reported a
close working relationship, however, two receptionists
felt that some members of the pharmacy team were not
always cooperative, being reluctant to take calls coming
through reception.
I get along with the pharmacy team generally but
when it comes down to having to crack down on
things, it is a bit like, “I know more than you”, if you
get what I mean from their end (R8).
They only wanted to issue and sign, which is
understandable. They didn’t want to take all the calls,
only the calls that were necessary. That was the hardest
part at the beginning but now they are fine (R6).
Participants’ opinions on the relationship with local
community pharmacies were mixed. One GP suggested
that the trust level was low (GP6) while one nurse
described the local pharmacist as really helpful (N1).
Examples were provided of the general practice phar-
macy team liaising with local community pharmacies.
One GP believed that the presence of the team could
improve the relationship with community pharmacists
and that the practice pharmacist could organise things
that would have taken (the GP) hours (GP3). Members
of the pharmacy team were also of the opinion that their
presence in the general practice had bridged the gap be-
tween the two pharmacy settings.
Participants mentioned that the pharmacy team were
involved in challenging local pharmacies on unethical
practices, including inappropriate community pharmacy
repeat prescription requests (N2 & GP2).
The relationship with the local pharmacies is quite an
interesting one. Obviously our pharmacy team here
know about a lot of tricks that people sometimes pull
that aren’t necessarily that ethical, so [the pharmacist]
and his team have been challenging them on things
that they don’t think are appropriate whereas we just
would never have known that it was happening so
that’s good. There is sometimes a tendency with local
pharmacies to call when they know that the pharmacy
team have left so that they get to talk to the doctors
instead but we are trying to work our way around
that, and say no, you need to call between this time
and this time in the morning to speak about any
medication queries (GP5).
Trust
There was a pervading sentiment from the participants
that they were all working together as a team to advance
patient care. Practice staff felt that the pharmacy team
had integrated well and cooperated effectively. Pharma-
cists and technicians reported feeling that they had been
accepted into the team with their views valued and con-
tributions appreciated. GPs stated that they trusted the
pharmacy team’s ability and this view was reinforced by
the pharmacy team. Both parties, however, noted the im-
portance of taking time to build up trust.
It does take time to build a relationship with anybody
in a practice and… I think there is an element of not
just his knowledge as a pharmacist but his practical
approach to applying that knowledge that makes you
trust him more and that probably encourages more
positive communication (GP3).
A few participants suggested that some GPs exhibited
initial distrust and a lack of engagement but felt that this
was no longer an issue in practices in which they had
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worked for a while. Pharmacists and two GPs (GP2
& GP3) noted that some GPs might feel threatened
by pharmacists.
I think there would always be a ‘them’ and an ‘us’ in a
way but it’s sort of merged a bit more now. I can see a
boundary, maybe not this surgery so much, but there’s
other surgeries that definitely like to keep a clear role
difference. A lot of GPs wouldn’t like to be put on the
same level as pharmacists I’ve noticed. Here’s a bit
different, there’s been a relationship longer, but a few
other surgeries where I've worked for the doctors there’s
a bit more tension but I think that will go with time
once they’ve worked together alongside each other a bit
more (PT4).
It’s got to do with personality. It’s the way that GPs
work, the pharmacists too. You’ve got to see them as
part of the team and not a competitor (GP2).
One GP compared this perceived threat to professional
boundaries and identity to that observed during the
introduction of nurse practitioners, although they
suggested that this sentiment might be stronger since
everything a nurse can do a GP can probably do,
whereas anything a pharmacist can do the GP probably
can’t (GP2). One manager believed that prejudices would
be a barrier to project expansion.
I think its overcoming prejudices of GPs too, allowing
someone else to come in and look at their medication
budget and prescribing and actually accepting the
advice of another clinical professional (M5).
Initial distrust was not limited to GPs with one pharma-
cist who visited nursing homes stating that some residen-
tial care nurses were very unhappy with their presence
and felt that they (the nurses) were being policed (CP1) by
the pharmacist. One general practice nurse (N3) described
her preference to speak to the GP with medication queries
despite acknowledging that a pharmacist’s medication
knowledge might be superior to that of a GP. Further-
more, another nurse (N6) believed that medication queries
were not the role of a pharmacist and that the GP
remained the most appropriate contact.
Communication
Participant’s views on communication with the phar-
macy team within the practice were mixed. Positive ex-
periences included the electronic communication system
that enabled rapid responses.
It’s really helpful using (the internal online messaging
system)… I can ask for advice from the pharmacy
team and they’re really good at getting back to you. So
for me it’s brilliant (N4).
Some members of the practice staff lacked awareness of
the pharmacy team’s working hours raising concerns
about short and unfixed hours of work that were a bar-
rier to effective communication. Some receptionists and
managers described a failure in communication when
the pharmacy team suspended the reauthorisation of
prescriptions pending a review but omitted to communi-
cate this to the receptionists.
Practice meetings were the main method of communi-
cation with many participants discussing their benefit.
The pharmacist’s contribution to education within the
practice was identified with many participants mention-
ing educational talks delivered by the pharmacy team as
well as instances of individual advice they received from
the pharmacist. GP1, however, questioned why techni-
cians did not regularly attend the practice meetings and
then acknowledged that the pharmacist liaised with the
rest of the pharmacy team after the meeting.
Next Monday we have the technicians speaking about
the electronic prescribing system to just give reminders
because it’s still quite a new process. You know top
tips, we try and keep it as open learning as possible for
everyone (M7).
Practicalities
Practicalities are defined, by the Oxford Dictionary of
English, as the aspects of a situation that involve the actual
doing or experience of something rather than theories or
ideas. A number of the practical issues surrounding phar-
macists in general practice were identified including the
physical location of the pharmacy team and their hours of
employment. The cost of employing a pharmacist was bal-
anced against savings and improvements both for the gen-
eral practice and the NHS, however, patients’ awareness of
the service was poor.
Location and space
A strong preference was expressed for the pharmacy
team to be located in house all day (GP6). In practices
where the pharmacy team was located on-site, partici-
pants reported easy personal access and the ability to
ask informal questions. Where the pharmacy team was
located off-site, however, they were viewed as a separate
entity (GP7) and aspects of communication were lost.
Having somebody in house, (it) is the corridor talk and
it’s difficult to quantify how helpful that is because you
can say, “Can I just pick your brains on something?” If
he wasn’t here, in the building, I don’t think I would
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think to ask him. Because he is in the building and
because I see him… I do think “Oh actually we’ve got a
pharmacist who can look into this” (GP3).
(Being located off-site has) been more of a challenge
because they (pharmacists) can’t just walk down to my
office and say “There’s a problem, can you help me?”
Communication wise we have phones, our computer
system, we can send instant messages, task, and email
so it’s not an issue. Having said that, when you lose
face-to-face contact, there could be more
misunderstanding and delays (M5).
One of the challenges most broadly identified was the
shortage of accommodation available to house extra
members of staff. GP5 & GP6 stated that the lack of ac-
commodation had directly prevented participation for
some practices in the national Clinical Pharmacists in
General Practice Pilot which was due to start.
The physical problems of the buildings and
communication I think are the main issues (M4).
Costs
The cost of employing a pharmacist was seen to be a
barrier, however, participants often counterbalanced this
opinion against savings generated by the pharmacy team,
decreased workloads, decreased prescribing errors and
improved patient safety. Participants also described in-
creased efficiency in dealing with the repeat prescribing
process with one manager (M1) reporting a reduction in
errors and medication-related complaints with more pa-
tients being called in for medication reviews.
Pharmacists in GP surgeries, I don’t really see it as
being optional if you consider the patient safety aspect.
I think… it can reduce… so many errors (GP3).
Some participants were also of the opinion that the qual-
ity of patient service had improved, with reasons varying
from a quicker repeat prescription turnaround time to
being able to offer the level of individual service for
which GPs did not have time. A nursing home pharma-
cist (CP1) noted that their role in monitoring patients
had led to a noticeable reduction in hospital admissions.
The pharmacy team’s contribution to the reduction in
practice drug budgets was widely discussed by a broad
spectrum of participants with two GPs directly attribut-
ing a 20% drop in the practice prescribing budget to the
pharmacy team. GP2 raised the point that although the
pharmacy team generated significant savings on drug ex-
penditure for the NHS the cost of employing the team
was borne entirely by the practice.
Patients’ access
Patients discussed the relative ease of obtaining an ap-
pointment with a pharmacist within the week in com-
parison to 1–3 weeks for a GP appointment. They
reported that long waits for GP appointments caused
them stress and made them feel like a burden to the
NHS. Patients were also very pleased with the duration
of their appointment comparing a 30-min pharmacist
appointment to 10–15 min with their GP and believed
that this allowed for a more beneficial consultation.
I got this appointment quite quick, so, whereas if it
was a doctor I think it was another 2 weeks or
something, which, because it was only to review my
medication I felt that’s quite a long time to wait just
for that, so this is a good way of doing it (PA2).
If 4 years ago I had the opportunity to talk to someone
like the pharmacist about this situation, it could have
been resolved [then]... The hour that I had in two
meetings with the pharmacist was more useful than
tens of appointments that I had with my GP (PA4).
Many patients expressed a strong willingness to see
the pharmacist again and were happy to book an ap-
pointment with the pharmacist rather than the GP often
stating that they did not want to bother the doctor with
“silly things” (PA3) and would rather free up GP appoint-
ments for those who might be more deserving.
All about my medication, he went through each and
every one of them and he agreed what I should be on
and what I should be told about, he agreed with most
of them except for this warfarin. He gave me
alternatives and he wrote it down… To get somebody
to talk to about my medication when there’s serious
people out there that need attending and doctors are
giving their time for me to sort my little problem out,
you know, whereas if you’ve got somebody like the
pharmacist, if you rung up to speak to him and he can
sort it out (PA3).
One patient, however, expressed concerns that as the
service becomes more established, appointments will
have to be shortened due to increased demand. Another
expressed preference for an out-of-hours appointment.
The cynical view is that once it gets introduced and
adopted, because it’s a popular move and if more
people find that they need that, so they all pile in and
you get one pharmacist here and everybody wants to
know a bit more about their drugs. So if they’re given
free access to him, he’ll be as busy as the doctor, if not
busier (PA5).
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Patients’ awareness of the presence of a pharmacist
within the practice was low with some failing to realise
that they had seen a pharmacist even when questioned
post-consultation, often assuming the interviewers were
referring to their community pharmacist.
I’ve never seen the pharmacist here. Oh, this is the
pharmacist? Absolutely excellent, but I’ve seen this
gentleman twice… I just made an appointment, I
thought, you know I was seeing one of the doctors
and I said to him I’ve never seen you before, are you a
new doctor, and he said “No, no”, he said “I’m a
pharmacist” and he explained to me. I have no idea
why they decided, I suppose they decided here,
that I was to see a pharmacist because it was more
appropriate because I’m old, I take about twelve kinds
of medicines (PA7).
One patient (PA3) felt that the service was under-
publicised and expressed concerns that there was no
mention of the pharmacist in any communication they
received from the practice.
And you say he’s been here a long time? How come he
never appears in any of the paperwork or letters or
anything? Because, you know, some letters we get from
the surgery and they’ve got all these doctors’ names on
it and all that, right? But the pharmacist’s name’s not
on it (PA3).
GP3 suggested that the potential inability of patients to
distinguish between a pharmacist and a doctor was a
challenge due to differing skillsets. GP6 described being
upset that patients do not take the initiative to visit a
community pharmacy to treat minor ailments and sug-
gested that the message doesn’t get through even though
they can be far better treated by a pharmacist who is
fantastic at referring people.
Discussion
Our findings relate to the experiences of the key stake-
holders in the Ealing GP Federation where pharmacy
services have been provided for several years. The model
used by this group of practices is possibly unique in
employing pharmacy technicians to undertake repeat
prescribing duties but findings could still be transferable
to other sites and models nationally and internationally.
Experiences were generally positive and included appre-
ciation of pharmacists’ knowledge of medicines, educa-
tional contribution to the practice and their methodical
approach to tasks. Receptionists reported increased effi-
ciency, decreased workload, decreased medicines related
complaints and a safer repeat prescription process under
the direction of a pharmacist. GPs spoke of decreased
workloads and more time for patients, resulting in im-
proved relationships. Pharmacists talked about increased
job satisfaction and a strong understanding of compe-
tencies and boundaries with some requesting further
training. There were, however, a few areas that could be
improved, including role definition, communication pro-
cesses, patients’ awareness of services, co-location of
pharmacists and general practice staff, and full-time ac-
cess to pharmaceutical services.
Mossialos et al. [19] reported a lack of policy-relevant
evidence to support the expansion of the traditional role
of community pharmacists and suggested that the adop-
tion of patient-centred responsibilities might be justified
by challenges to the health system such as workforce
shortages, an ageing population and increased demand
for services. Ours is the first research of its kind in the
UK. It addresses the expansion of pharmacists’ roles into
general practice and reports findings that pre-empt any
to come from pilot sites because of the pre-existing
nature of the services studied. In essence, it provides a
snapshot into what the future might look like and how
the pilot sites could evolve in time. It also enables identi-
fication of avoidable pitfalls. Our study provides some
insight into the employment of pharmacists in general
practice that can feed into future formal evaluations and
inform policy development. Our research is also unique
in the inclusion of all stakeholders, including patients, in
the general practice environment. This allowed for a
broad range of experiences from a variety of partici-
pants, enabling the findings to be extrapolated to similar
general practice situations. Other strengths include the
semi-structured interview technique which enabled par-
ticipants to take the lead in interviews to discuss issues
of importance to them. Rigour was ensured by the use
of multiple researchers (interviewers and analysts), peer
debriefing regarding interviews and developing analytical
understandings and regular group meetings to develop
consensus on codes, categories and themes.
Limitations include the small number of participants
in some stakeholder groups, especially the patients, and
the brevity of some interviews due to time constraints of
the participants. This work needs to be repeated with
larger groups from a variety of practices nationwide or
in practices that use very different models of pharma-
cists’ involvement.
Role development within multi-disciplinary teams
There is a growing body of literature, mostly from
overseas, about the integration of pharmacists into pri-
mary care teams [11, 12, 20, 21]. Much of the reported
work focuses on professional role development and
identity within multi-disciplinary teams and mirrors
many of the findings of our study around role definition
and inter-professional understanding, expectations and
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responsibilities. Farrell et al., as part of their IMPACT
(Integrating Family Medicine and Pharmacy to Advance
Primary Care Therapeutics) project in Ontario, Canada,
implemented a mentorship scheme to reduce the stress
of adapting to new roles and to promote professional de-
velopment [22, 23]. In 2013, they produced guidelines
for the integration of pharmacists into primary care
teams with practical recommendations similar to ours.
We suggest that there might be valuable lessons from
this work for UK health professionals involved in the in-
tegration of pharmacists into general practice, particu-
larly the demonstration of leadership and vision, and the
development of practice support networks. Luetsch and
Rowett [24] showed in Australia that inter-professional
communication skills training “enhanced professional
identity, credibility and the ability to build a collabora-
tive working relationship with other health profes-
sionals” and improved role satisfaction for pharmacists.
Some of the participants in our study hinted at profes-
sional boundary and identity issues with comments
about ‘knowing limitations’ and ‘deskilling’. Inter- and
intra-disciplinary boundaries (between and within pro-
fessions) have been identified by many researchers as
barriers to integrated patient care delivery by multi-
disciplinary teams [25–28]. Collaboration is affected by
“attempts to defend existing boundaries, specialised
knowledge, and pre-existent practices” (Liberati p 32)
and, we would add, discipline-specific professional
identities. Bardet et al. [29] identified the key elements to
initiating collaborative practices as “trust, interdepend-
ence, perceptions and expectations about the other health-
care professionals, skills, interest for collaborative practice,
role definition and communication” (p612). According to
Liberati [26], evidence of how multi-disciplinary teams de-
velop and function, including the social factors that influ-
ence knowledge and practice integration is still limited
(p32), and, if issues of professional boundaries and iden-
tities are not addressed, healthcare practitioners will fall
back on their formal roles rather than developing new
ways of working together (p38).
Given that we have reported in our study that it takes
time to build trusting professional relationships, we sug-
gest that the strengthening of inter-professional commu-
nication skills training at both undergraduate and
postgraduate levels for all multidisciplinary team mem-
bers followed up with mentorship in general practice
could help break down initial barriers and trust issues
more quickly. Since our research was conducted, the
Centre for Pharmacy Postgraduate Education (CPPE –
funded by Health Education England and hosted by The
University of Manchester) has developed a range of clin-
ical programmes and study days for pharmacists and
pharmacy technicians. Similarly, the Royal College of
General Practitioners (RCGP) has endorsed localised
general practitioner/pharmacist/patient joint-working
strategies. While we applaud these initiatives we suggest
that more could be done around inter-professional edu-
cation involving all members of general practice teams
and including patients.
More recently (2016) the Royal Pharmaceutical Society
has produced The Ultimate Guide for Pharmacists
Working in GP Practices. It includes person spe-
cifications and job descriptions, business cases, practical
guidance (for example indemnity and insurance, using
IT systems and consultation skills), relevant legal and
regulatory frameworks, managing and optimising medi-
cines, and professional and clinical guidance [30]. This
resource together with our findings and recommenda-
tions below provide useful guidance and insight for
pharmacists and general practices venturing into this
type of partnership.
Patients’ awareness of pharmacy services
There is very little contemporary knowledge and qualita-
tive data on patients’ awareness and views of receiving
pharmaceutical services in general practice in the UK
and even less on their information needs. Limited evi-
dence, including from this study, suggests a lack of pub-
lic awareness about the level of expertise of pharmacists
and the range of services already provided [5, 31, 32].
NHS, Department of Health and RPS policy statements
and strategic directives over the past decade have all fo-
cussed on building on the strengths of pharmacy and de-
livering improvements in and extension of pharmaceutical
services. Thus there is a mismatch between the thrust of
policy development and strategic directives [33, 34], ser-
vice design and delivery [2] and public understanding.
Pharmacy in England: Building on strengths – delivering
the future (2008) called for wider public understanding of
the breadth of services, including a mass communications
programme and mapping of target audiences. We suggest
that this work is sorely needed and long overdue.
Recommendations
The following recommendations are made:
 Develop clear definitions of roles and basic duties,
even if they are flexible enough to allow for further
development, and provide induction and training
needs analyses for new staff members and constant
role reminders at regular meetings of all staff members
 Allow time for multi-disciplinary team building,
including with surrounding community pharmacists,
and the development of trust and leadership
 Establish reliable means of communication – email,
telephone, electronic management systems – that
include documentation of activities and decisions
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 Ideally, provide full-time, on-site pharmacy services
or at least regular hours with strategies to prevent
deskilling of other health professionals
 Work with patients on their information needs
about the pharmacy services provided and the most
appropriate health professional to consult.
Further research is required on the different models of
incorporating pharmacists, technicians and pharmacy
services into general practice. Work is needed on phar-
macy intra-professional boundaries, especially the rela-
tionships between community pharmacy and general
practice personnel. Further work is also required with
patients about their preferences for receiving these ser-
vices, their concerns and information needs.
Conclusions
Although the integration of pharmacists into general
practice is not entirely new there are no recently pub-
lished UK evaluations of the services provided or the
various models in existence. The NHS England Clinical
Pharmacists in General Practice Pilot is currently being
implemented (and further rolled-out) so while we await
evaluations, projects like the one reported here will be
crucial in providing guidance for integration of pharma-
ceutical services into primary care, service improvement
and expansion, future policy development and the edu-
cation of health practitioners. In addition, if patients are
to benefit from collaborations like this, they need to be
involved in service design and public education. Further-
more, general practitioners will need to be vocal about
the advantages and their support for pharmaceutical ser-
vice inclusion in the general practice team.
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